Form 4: Nuvalent Insider Trading: Flynn Acquires Shares

James E. Flynn, a director and significant stakeholder in Nuvalent, Inc., reported the acquisition of 3,444 shares of Class A Common Stock on June 16, 2026.

Summary

• James E. Flynn, identified as a Director, 10% Owner, and other roles at Nuvalent, Inc. (NUVL), reported a transaction on June 16, 2026.
• The transaction involved the acquisition of 3,444 shares of Class A Common Stock.
• These shares were acquired at a price of $0, indicating they were likely part of a restricted stock unit (RSU) grant or similar equity award.
• Following this transaction, Flynn's beneficial ownership of Class A Common Stock is reported as 3,444 shares directly, with significant indirect holdings through various Deerfield entities.
• The filing also details substantial indirect beneficial ownership through Deerfield Management Company, L.P., Deerfield Partners, L.P., Deerfield Private Design Fund IV, L.P., and Deerfield Healthcare Innovations Fund, L.P.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While insider transactions can be positive indicators, this specific report details equity awards rather than open market purchases, and includes standard disclaimers, making it neither strongly positive nor negative.

Positives

• Insider acquisition of shares, even if through equity awards, can signal confidence from management and key stakeholders.
• The acquisition of 3,444 shares by James E. Flynn on June 16, 2026, at no cost, suggests an alignment of interest between the insider and the company's shareholders.
• The filing confirms substantial indirect beneficial ownership by Deerfield entities, indicating continued significant investment and oversight.

Negatives

• The acquisition price of $0 for the 3,444 shares suggests these were not open market purchases but rather equity awards, which do not represent new capital investment by the insider.
• The sheer volume of indirect holdings through various funds, while indicating significant stake, also points to a complex ownership structure that might warrant further scrutiny regarding ultimate control and decision-making.

Risks

• The RSUs granted to Dr. Cameron Wheeler, held for the benefit of Deerfield Management, vest in full on the earlier of June 16, 2027, or the company's next annual meeting, contingent on continued service. Any departure before vesting could impact beneficial ownership.
• The disclaimer of beneficial ownership for securities except to the extent of indirect pecuniary interest suggests potential complexities in attributing ownership and control, which could be a point of regulatory or investor concern.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on a change in beneficial ownership.

Management Comments

• Cameron Wheeler, a partner in Deerfield Management, serves as a director of the Issuer.
• The reported shares of Class A Common Stock are issuable under restricted stock units ('RSUs') granted to Dr. Wheeler, which are held for the benefit, and at the direction, of Deerfield Management.
• Each RSU represents the right to receive one share of the Issuer's Class A Common Stock.
• The RSUs vest in full on the earlier of June 16, 2027 or the date of the Issuer's next annual meeting of stockholders, subject to Mr. Wheeler's continued service to the Issuer through the applicable vesting date.
• For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for reporting insider transactions. The nature of this filing, detailing equity awards rather than open market purchases, is common for executives and directors receiving compensation in the form of stock. The significant holdings by Deerfield Management indicate a substantial institutional investor presence, which is typical in the biotechnology and pharmaceutical sectors where Nuvalent operates.

Related Party Transactions

• The filing details transactions and beneficial ownership related to James E. Flynn and various entities managed by Deerfield Management Company, L.P., where Flynn is the sole member of the general partner of several key entities. This represents a related party structure.

Stakeholder Impact

• Shareholders: The acquisition of shares via equity awards aligns insider interests with shareholder value, though it does not represent new capital investment. The significant indirect ownership by Deerfield entities suggests a stable, long-term institutional investor.
• Employees: The RSU grant to Dr. Wheeler indicates a form of employee compensation tied to company performance and continued service.
• Management: The filing confirms the roles and beneficial ownership of key individuals and entities involved in the company's governance and investment.

Next Steps

• The restricted stock units are subject to vesting on June 16, 2027, or the next annual meeting date, contingent on continued service.
• Further transactions by James E. Flynn or Deerfield entities may be reported on subsequent Form 4 filings.

Key Dates

Keywords

Nuvalent, NUVL, Form 4, Insider Trading, Beneficial Ownership, Class A Common Stock, Restricted Stock Units, Deerfield Management, James E. Flynn, Equity Award